Pendal Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,534
| Closed | -$695K | – | 448 |
|
|
2022
Q2 | $695K | Buy |
4,534
+2,701
| +147% | +$414K | 0.01% | 308 |
|
|
2022
Q1 | $297K | Sell |
1,833
-502
| -21% | -$81.3K | ﹤0.01% | 448 |
|
|
2021
Q4 | $316K | Buy |
+2,335
| New | +$316K | ﹤0.01% | 500 |
|
|
2021
Q2 | – | Sell |
-16,404
| Closed | -$1.78M | – | 548 |
|
|
2021
Q1 | $1.78M | Buy |
16,404
+3,854
| +31% | +$417K | 0.02% | 238 |
|
|
2020
Q4 | $1.35M | Sell |
12,550
-20,625
| -62% | -$2.21M | 0.01% | 256 |
|
|
2020
Q3 | $2.91M | Sell |
33,175
-56,134
| -63% | -$4.92M | 0.04% | 140 |
|
|
2020
Q2 | $8.77M | Buy |
89,309
+81,879
| +1,102% | +$8.04M | 0.12% | 78 |
|
|
2020
Q1 | $566K | Buy |
+7,430
| New | +$566K | 0.01% | 261 |
|
|
2019
Q3 | – | Sell |
-81,903
| Closed | -$5.96M | – | 447 |
|
|
2019
Q2 | $5.96M | Sell |
81,903
-62,874
| -43% | -$4.57M | 0.08% | 114 |
|
|
2019
Q1 | $11.7M | Buy |
144,777
+131,278
| +973% | +$10.6M | 0.16% | 77 |
|
|
2018
Q4 | $1.24M | Sell |
13,499
-34,207
| -72% | -$3.15M | 0.02% | 250 |
|
|
2018
Q3 | $4.51M | Sell |
47,706
-27,135
| -36% | -$2.57M | 0.06% | 143 |
|
|
2018
Q2 | $6.93M | Sell |
74,841
-19,722
| -21% | -$1.83M | 0.09% | 138 |
|
|
2018
Q1 | $8.95M | Buy |
94,563
+1,036
| +1% | +$98.1K | 0.12% | 123 |
|
|
2017
Q4 | $9.04M | Sell |
93,527
-23,621
| -20% | -$2.28M | 0.12% | 127 |
|
|
2017
Q3 | $10.5M | Buy |
+117,148
| New | +$10.5M | 0.14% | 121 |
|